HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Conquer, J. A. Articles by Holub, B. J. Search for Related Content PubMed PubMed Citation Articles by Conquer, J. A. Articles by Holub, B. J. Social Bookmarking                      What's this?

The Journal of Lipid Research, Vol. 39, 286-292, February 1998
Copyright © 1998 by Lipid Research, Inc.

Original Article

Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background

Correspondence to: Bruce J. Holub.

There is evidence to indicate that the high rates of coronary heart disease and myocardial infarction amongst Indians of Asian descent may be partly related to circulating non-esterified fatty acids (NEFA). As docosahexaenoic acid (DHA,22:6n–3) in NEFA form has been found to exhibit anti-platelet aggregatory and anti-arrythmic potential in vitro, the effect of supplementary DHA was examined in healthy subjects of Asian Indian background. Furthermore, time- and dose-dependent changes in absolute levels of DHA as NEFA or phospholipid (PL) were compared. The subjects consumed 8 capsules daily of placebo (DHA-free) or low DHA (0.75 g/day)or high DHA (1.50 g/day) over 6 wks. Fasting blood samples were drawn at days 0, 21, and 42 for analysis of serum lipid/lipoprotein composition. No significant effect of DHA supplementation on the levels of serum lipid/lipoproteins (including Lp[a]) or blood pressure was found. However, the DHA level in serum phospholipid rose by 167% overall with low-dose supplementation (from 2.4–6.4 mol%) but only by an additional 23% upon doubling the dose from 0.75 g to 1.50 g/day. Furthermore, after 6 weeks of supplementation with 0.75 g or 1.5 g DHA/day, absolute concentrations of DHA as PL were not significantly different from the corresponding 3-week values.

Interestingly, the absolute concentrations of serum DHA as NEFA showed a marked rise with low-dose supplementation (by 212% overall, from 2.4 to 7.5 µM) and a further 70% rise (to 12.7 µM) upon doubling the supplementation from 0.75 to 1.50 g/day. As well, the 6-week concentrations (DHA-NEFA) were significantly different than the corresponding 3-week values at both dose levels. Elevation of circulating DHA-NEFA levels via DHA supplementation, as shown herein, to concentrations that exhibit anti-thrombotic and anti-arrhythmic potential in vitro needs to be extended to trials where clinical end-points are determined.—Conquer, J. A., and B. J. Holub. Effects of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. J. Lipid Res. 1998. 39: 286–292.

Supplementary key words: docosahexaenoic acid (DHA), non-esterified fatty acids (NEFA), cardiovascular disease

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Fekete, T. Marosvolgyi, V. Jakobik, and T. Decsi Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review Am. J. Clinical Nutrition, June 1, 2009; 89(6): 2070S - 2084S. [Abstract] [Full Text] [PDF]

				C. D. Allred, D. R. Talbert, R. C. Southard, X. Wang, and M. W. Kilgore PPAR{gamma}1 as a Molecular Target of Eicosapentaenoic Acid in Human Colon Cancer (HT-29) Cells J. Nutr., February 1, 2008; 138(2): 250 - 256. [Abstract] [Full Text] [PDF]

				S. S. N. Kolar, R. Barhoumi, E. S. Callaway, Y.-Y. Fan, N. Wang, J. R. Lupton, and R. S. Chapkin Synergy between docosahexaenoic acid and butyrate elicits p53-independent apoptosis via mitochondrial Ca2+ accumulation in colonocytes Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G935 - G943. [Abstract] [Full Text] [PDF]

				L. M Arterburn, E. B. Hall, and H. Oken Distribution, interconversion, and dose response of n-3 fatty acids in humans Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1467 - 1476S. [Abstract] [Full Text] [PDF]

				Y. Ng, R. Barhoumi, R. B. Tjalkens, Y.-Y. Fan, S. Kolar, N. Wang, J. R. Lupton, and R. S. Chapkin The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes Carcinogenesis, November 1, 2005; 26(11): 1914 - 1921. [Abstract] [Full Text] [PDF]

				D. Mozaffarian, A. Geelen, I. A. Brouwer, J. M. Geleijnse, P. L. Zock, and M. B. Katan Effect of Fish Oil on Heart Rate in Humans: A Meta-Analysis of Randomized Controlled Trials Circulation, September 27, 2005; 112(13): 1945 - 1952. [Abstract] [Full Text] [PDF]

				J. A Lovegrove, S. S Lovegrove, S. V. Lesauvage, L. M Brady, N. Saini, A. M Minihane, and C. M Williams Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians Am. J. Clinical Nutrition, June 1, 2004; 79(6): 974 - 982. [Abstract] [Full Text] [PDF]

				Y.-Y. Fan, T. E. Spencer, N. Wang, M. P. Moyer, and R. S. Chapkin Chemopreventive n-3 fatty acids activate RXR{alpha} in colonocytes Carcinogenesis, September 1, 2003; 24(9): 1541 - 1548. [Abstract] [Full Text] [PDF]

				M. Kouba, M. Enser, F. M. Whittington, G. R. Nute, and J. D. Wood Effect of a high-linolenic acid diet on lipogenic enzyme activities, fatty acid composition, and meat quality in the growing pig J Anim Sci, August 1, 2003; 81(8): 1967 - 1979. [Abstract] [Full Text] [PDF]

				D. E. Williard, S. D. Harmon, T. L. Kaduce, M. Preuss, S. A. Moore, M. E. C. Robbins, and A. A. Spector Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes J. Lipid Res., September 1, 2001; 42(9): 1368 - 1376. [Abstract] [Full Text] [PDF]

				S. I. Rapoport, M. C. J. Chang, and A. A. Spector Delivery and turnover of plasma-derived essential PUFAs in mammalian brain J. Lipid Res., May 1, 2001; 42(5): 678 - 685. [Abstract] [Full Text]

				E. D. Collett, L. A. Davidson, Y.-Y. Fan, J. R. Lupton, and R. S. Chapkin n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes Am J Physiol Cell Physiol, May 1, 2001; 280(5): C1066 - C1075. [Abstract] [Full Text] [PDF]

				J. L. Arrington, D. N. McMurray, K. C. Switzer, Y.-Y. Fan, and R. S. Chapkin Docosahexaenoic Acid Suppresses Function of the CD28 Costimulatory Membrane Receptor in Primary Murine and Jurkat T Cells J. Nutr., April 1, 2001; 131(4): 1147 - 1153. [Abstract] [Full Text]

				S. S. D. Nair, J. Leitch, J. Falconer, and M. L Garg Cardiac (n-3) Non-Esterified Fatty Acids Are Selectively Increased in Fish Oil-Fed Pigs following Myocardial Ischemia J. Nutr., August 1, 1999; 129(8): 1518 - 1523. [Abstract] [Full Text]